AI in drug discovery

News

Lab-in-a-loop specialist Relation attracts Novartis alliance

UK-based AI and multi-omics company Relation Therapeutics will seek out targets for allergic diseases on behalf of Novartis in a $1.7bn-plus alliance.

R&D

pharmaphorum podcast Episode 225, Simon Kohl, Latent Labs

Towards a democratic era of medicine, with Simon Kohl

In a new episode, Simon Kohl discusses Latent Labs’ emergence from stealth, as well as protein design and drug discovery acceleration in more detail.

News

Merck partners Valo on $3bn, AI-based Parkinson's project

Merck has teamed up with Valo Health on a project to apply AI to the discovery of novel drug targets and drugs for Parkinson's.

News

Change at the top of Recursion as co-founder leaves CEO role

After 12 years as CEO of 'techbio' player Recursion, Chris Gibson is switching to the role of chair and will be replaced by Najat Khan.

News

Lilly partners NVIDIA to build 'most powerful' supercomputer

Eli Lilly and NVIDIA have joined forces on an ambitious plan – building pharma's most powerful AI-powered supercomputer for drug discovery.

News

Google claims quantum advance could speed up drug discovery

Google has claimed an advance in quantum computing that is a milestone towards its practical applications in areas like drug discovery.

Lab-in-a-loop specialist Relation attracts Novartis alliance

Towards a democratic era of medicine, with Simon Kohl

Merck partners Valo on $3bn, AI-based Parkinson's project

Change at the top of Recursion as co-founder leaves CEO role

Lilly partners NVIDIA to build 'most powerful' supercomputer

Google claims quantum advance could speed up drug discovery

CHMP decision levels the playing field for GSK's RSV jab

How to meet your physicians where they are online

AI in drug discovery

Editor's Picks